<DOC>
	<DOC>NCT00104455</DOC>
	<brief_summary>This trial is conducted in the United States of America (USA). The purpose of this trial is to investigate the dose response to recombinant factor VIIa in healthy volunteers when administered for bleed.</brief_summary>
	<brief_title>Dose Response to Recombinant Factor VIIa When Administered for Bleed</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Ages Eligible for Study: 18 Years 60 Years</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>rFVIIa</keyword>
	<keyword>Punch Biopsy</keyword>
	<keyword>Dose Response</keyword>
	<keyword>Healthy People Programs</keyword>
</DOC>